Thursday, September 10, 2026

Zack Buckley on $PRTH's take private

Priority Technology’s chairman offered $6.00 to $6.15 a share to take PRTH private, while Zack Buckley argues Treasury Solutions and comparable sales support $12 to $19.

PRTH $641M

Yet Another Value Podcast Sep 10 3 clicks

Sep 8 LOGC $675M

ContextLogic Acquires gChem (LOGC): Update and Valuation

Hidden Gems Investing 5 clicks

Sep 6 TII $284M

Titan Mining Q2 Update

Sylence Capital 4 clicks

From X

@P_Remarks Sep 10

Prepared Remarks on X

Robert DeMartini and the entire board of $PRPL qualify for my special rule of “if you turn down multiple acquisition offers and then the company goes down 90% you go to jail for 5 years and all comp is clawed back and dividended back to shareholders”

@ACapitalLP Sep 10

A Capital on X

Just want to check in here, thx. $ALOY https://t.co/f8zOpxU1CK

@natstewart5 Sep 10

Nat Stewart on X

Great @YetAnotherValue interview with Zack Buckley on Priority Technology $PRTH out today. If you had told me that PRTH would only be up 65% (including massive, unwarranted share-price volatility) from my 5/2024 article after: ° Enormous capital structure improvements (expensive pref was strangling profitability) ° Successful deleveraging ° Solid business execution I would have been very surprised. It is a shame CEO Priore chose a take-private offer rather than capital allocation/return strategy (which I advocated for). Would have been easy enough to stabilize the equity and in my view rocket it higher over time - creating a successful, useful public equity and track record.

@DeepSailCapital Sep 10 1 click

Deep Sail Capital on X

Sobering one: of 31 distinct names, only 2 have actually reached my Realistic Valuation target. $EVTL and $RR. Median downside capture on the Sept '25 list: 73% of the decline I forecast. On the 2026 lists: 22-41%. Direction right. Magnitude still pending. This means there is still lots of meat on the bone in many of these names.

@DeepSailCapital Sep 10

Deep Sail Capital on X

Across all 110 position-instances: Average short return: +25.7%Median: +23.1%Hit rate: 81% — 89 of 110 names fell Best call, and it wasn't close: $EVTL Vertical Aerospace $5.00 → $0.58 Top performer on all five lists. The Sept '25 entry is +88%. Even the July '26 entry is +66%. The company flagged going-concern risk in a filing this month.

@DeepSailCapital Sep 10

Deep Sail Capital on X

The rest of the Sept '25 podium — a full year of holding: $EVTL +88% $SMR +77% $LVWR +76% $OKLO +73% $BTQ +73% $SOUN +69% $RGTI +67% 19 of the 20 names on that list fell. Nineteen.

@stockgutter Sep 10

SG on X

@BertrandPirel to what do you attribute the substantial availability (1.85m shares) and low borrow cost (3.25%) for $GPRO at IBKR?

@BlueDuckCap Sep 10

BDC on X

Astute observation here. $STLN could not be better situated for the current environment, imo. https://t.co/sy97F9J9YU

A Busted Businesses or a Cyclical Bottom?

Two U.S. protein-snacking companies lost $6 billion in market value as impairments, inventory growth and margin pressure test whether the…

SMPL $852MBRBR $920M

The Value Road Sep 2 12 clicks

Sangamo Bankruptcy (SGMOQ)

Sangamo Therapeutics’ Chapter 11 asset sales leave common equity tied to $100 million in PTC Fabry therapy approval milestones and a…

SGMO $60M

Triple S Special Situations Investing Sep 2 6 clicks

Hydreight Technologies: A Strong Quarter With Some Yellow Flags (Rating Downgrade)

Hydreight Technologies' Q2 revenue rose 12% sequentially to $28 million, while gross margin fell to 19.4% and cash burn stayed elevated,…

HYDTF $120M

Fernanda Galvez Jalil Sep 2 1 click

An ATM that starts to spit out cash

Andrada Mining’s Uis ore sorter targets higher tin grades and lower unit costs after FY26 operating cash flow reached £4.7 million, but…

ATMTF $195M

The Oak Bloke Sep 2 7 clicks

Tectonic Therapeutic: Competitor Data Strengthens The TX45 Bull Case

Tectonic Therapeutic's TX45 CpcPH-HFpEF program gains support from Merck's CADENCE data; Phase 1b hemodynamics and cash through Q1 2029 set…

TECX $466M

Equity Eagle Sep 2 2 clicks

EVC Update

EVC reported a solid second quarter and outlook.

EVC $666M

Nat Stewart - Stock Picking Newsletter Sep 1 15 clicks

$LMB: Limbach missed the data center boom. Is that the opportunity? | 1 Main Capital

Limbach's EBITDA fell 30% as organic revenue declined, but 1 Main Capital calls the weakness temporary and views CYMCOR as its first…

LMB $572M

Yet Another Value Podcast Sep 1 9 clicks

IEH Corporation: Research Note

IEH Corporation won $6.5 million of APKWS orders, lifting backlog above $45 million as defense connector demand drives capacity expansion.

IEHC $74M

Atrium Research - Equity Research Sep 1 1 click

GoPro sold itself at 9:20 AM to get ahead of a meme stock

GoPro rushed out its Starman Optical merger after Markiplier-driven buying sent GPRO up roughly 90% premarket, offering shareholders $1.14…

GPRO $275M

Yet Another Value Blog Sep 1 4 clicks

Shattuck Labs: A Receptor-Side Bet On The TL1A Boom

Shattuck Labs pivots to DR3-targeted IBD therapy SL-325, funded through a Phase 2b readout as it competes with anti-TL1A drugs.

STTK $638M

Equity Eagle Sep 1

RCKY · long

Rocky Brands INC

Rocky Brands, a nearly century-old footwear maker, sells owned workwear, western and recreational brands into industrial and consumer end…

RCKY $338M

Value Investors Club May 13

Actionable Ideas Update - 08/20/2024

Cipher Pharmaceuticals’ $89.5 million Natroba acquisition doubles EBITDA to about $24 million and adds U.S.

CPHRF $245M

Raging Bull Investments Aug 20

SCIA- SCI Engineered Materials

SCIA generates $28 million of revenue from thin-film materials, with 78% of sales tied to one customer, while expanding into defense…

SCIA $39M

Sylence Capital Aug 15

ALTO- ALTO ingredients

ALTO Ingredients trades near half of book value after plant upgrades and lower corn prices set up a recovery in crush margins and cash flow.

ALTO $289M

Sylence Capital Aug 15 1 click

Cronos Group Update: A multi-bagger in the making?

Cronos Group's Q2 net revenue rose 46% to $27.8 million as Canadian cannabis volumes and market share grew, while its cash balance remained…

OGI $154M

Raging Bull Investments Aug 14

Notes and Updates

ECIP recipient banks could repurchase Treasury preferred shares at steep discounts, potentially lifting book value, while Hawaiian Electric…

UBAB $197M

Exploring with Alluvial Capital Aug 14

Intriguing Patent Litigation Situation ($FNCH)

Finch Therapeutics faces a jury verdict on FMT patent claims against Ferring’s Rebyota; a win could bring damages and royalties, while a…

FNCHQ $17M

Multibagger Monitor Aug 8 2 clicks

[$QRHC] Quest Resource Holding Corp

Quest Resource, a $200 million asset-light waste broker, manages 100-plus waste streams through 3,500 vendors and derives more than 90% of…

QRHC $29M

Lewistown Capital Aug 6

Mereo Biopharma

Mereo Biopharma has two late-stage assets, seeks non-dilutive financing for alvelestat Phase 3 trials, and reports cash runway through 2027.

MREO $59M

Raging Bull Investments Jul 23

10x or Bust? Pure Play Fighting GLP-1 Side Effects ($IBIO)

IBio’s $20 million, debt-free valuation is a high-risk bet that it can partner a myostatin inhibitor for GLP-1-related muscle loss before…

IBIO $77M

Multibagger Monitor Jun 3 1 click

Thursday, September 10, 2026

Prepared Remarks on X

A Capital on X

Nat Stewart on X

Deep Sail Capital on X

Deep Sail Capital on X

Deep Sail Capital on X

SG on X

BDC on X

Investor Letters

Publications we follow

Newsletters 91

YouTube 4

Blogs 12

Seeking Alpha 36 of 186

X accounts we follow

Investor letters we follow

Sectors